Literature DB >> 13883112

Thorotrast tumours. A review of the literature and report of two cases.

S DAHLGREN.   

Abstract

Entities:  

Keywords:  NEOMYCIN/etiology; THORIUM/toxicology

Mesh:

Substances:

Year:  1961        PMID: 13883112

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand        ISSN: 0365-5555


× No keyword cloud information.
  9 in total

1.  [Late lesions following thorotrast use].

Authors:  H Gaus; M Gülzow; G Meyer-Hofmann
Journal:  Klin Wochenschr       Date:  1966-01-01

2.  Cancer hazards of the pharmacy.

Authors:  G M Bonser
Journal:  Br Med J       Date:  1967-10-28

Review 3.  Historical review of the causes of cancer.

Authors:  Clarke Brian Blackadar
Journal:  World J Clin Oncol       Date:  2016-02-10

4.  Haemangioendothelioma (Kupffer cell angiosarcoma), myelofibrosis, splenic atrophy, and myeloma paraproteinaemia after parenteral thorotrast administration.

Authors:  R C Jennings; S E Priestley
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

5.  Primary adenocarcinoma of the bile ducts. Clinical characteristics and natural history.

Authors:  J T Bruggen; M S McPhee; P S Bhatia; J M Richter
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

6.  Hepatoma induced by thorium dioxide (thorotrast).

Authors:  J S MacKay; R C Ross
Journal:  Can Med Assoc J       Date:  1966-06-18       Impact factor: 8.262

7.  Thorotrast-induced ruptured hepatic angiosarcoma.

Authors:  M V Azodo; O H Gutierrez; T Greer
Journal:  Abdom Imaging       Date:  1993

8.  Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology.

Authors:  H Popper; L B Thomas; N C Telles; H Falk; I J Selikoff
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

9.  Surgical treatment of cholangiocellular carcinoma.

Authors:  R Pichlmayr; P Lamesch; A Weimann; G Tusch; B Ringe
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.